Journal profile · Medicine-Medicine (all)

EClinicalMedicine

ISSN 2589-5370 · Elsevier · United Kingdom

EClinicalMedicine: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 12.55; fully open access; APC about USD 6,810; median 133 days to acceptance (106 articles, last 24 months); 691 articles in 2025; indexed in SCIE and Scopus.

Impact factor12.55Latest value listed by LetPub
CAS zoneZone 1 · Medicine2025 upgraded edition, major category · Top journal · 2026 Xinrui edition Zone 1 · Medicine
Review time133 daysMedian, submission to acceptance · 106 articles, last 24 months · PubMed
APCUSD 6,810Fully open access
Acceptance—No reports yet
Articles per year6912025 · OpenAlex count

Scope

Aims, scope and focus

EClinicalMedicine is published by Elsevier and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and Long-Term Effects of COVID-19, together about 27.2% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)

eClinicalMedicine is a gold open access clinical journal that publishes original research to help frontline health professionals navigate the complex and rapid health transitions facing societies worldwide. The journal helps practitioners solve the problems and challenges of health care across all communities. From diagnosis to treatment, prevention to health promotion and protection, it will integrate disciplines across all specialties and across the life course with the goal of strengthening health systems as core institutions in our societies. It is a journal that has the courage and vision to rethink and reframe the future of health and health care.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Medicine (all)

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. COVID-19 Clinical Research StudiesMedicine11.1%
  2. SARS-CoV-2 and COVID-19 ResearchMedicine9.4%
  3. Long-Term Effects of COVID-19Medicine6.7%
  4. HIV/AIDS Research and InterventionsMedicine5.5%
  5. COVID-19 and Mental HealthPsychology4.6%
  6. Global Maternal and Child HealthMedicine4.5%
  7. Vaccine Coverage and HesitancySocial Sciences4.2%
  8. Global Cancer Incidence and ScreeningMedicine4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorMedicine, General & InternalZone 1

Top journal: yesReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorMedicine, General & InternalZone 1

Top journal: yesReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorMedicine, General & InternalZone 1

Top journal: yesReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
12.55LetPub ·
Impact factor (publisher)
12.8Publisher website ·
CiteScore 2026-06
17.3LetPub ·
CiteScore (publisher)
17.3Publisher website ·
SJR 2026-06
4.17LetPub ·
SNIP 2026-06
3.56LetPub ·
h-index
151OpenAlex ·
i10-index
2,406OpenAlex ·
2-year mean citedness
12.3OpenAlex ·
Self-citation rate
0.8%LetPub ·
Share of gold OA articles
99.82%LetPub ·

Volume

Articles per year
620LetPub ·

Articles by year OpenAlex count · 4,142 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026497497435
20256916915,541
202463363316,431
202356956921,073
202254554524,730
202153753731,540

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

133 daysMedian, submission to acceptance · P25–P75 100 days – 158 days

Acceptance to online
median 19 days (106 articles)
Submission to online
median 152 days
Sample
106 articles with submission and acceptance dates (1,276 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 10 weeksLetPub ·
Submission to first decision
14 daysPublisher website ·
First decision after review
40 daysPublisher website ·
Submission to acceptance
112 daysPublisher website ·
Acceptance to publication
21 daysPublisher website ·
Submission to publication (journal-reported)
about 19 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 6,810YesCC BY, CC BY-NC, CC BY-NC-ND
OpenAlexUSD 5,780 / EUR 5,410 / GBP 4,630 / JPY 716,890——
LetPubUSD 5,000Yes—
Publisher websiteUSD 6,810——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Policy excerpts from the journal's websiteOpen access
Open access Open Access

Article Publishing Charge (APC): USD 6,810 (excluding taxes). This journal is taking part in the GPOA program.Review this journal’s open access policy.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Elsevier
Country or region
United Kingdom
Language
English
ISSN
2589-5370
Official links

FAQ

Frequently asked questions about EClinicalMedicine

What CAS zone is EClinicalMedicine in?

In the 2025 upgraded edition of the CAS Journal Ranking, EClinicalMedicine is in Zone 1 of Medicine, and in Zone 1 of the minor category Medicine, General & Internal; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of EClinicalMedicine?

The latest impact factor listed by LetPub is 12.55; CiteScore 17.3, h-index 151.

How long does peer review take at EClinicalMedicine?

Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 133 days (interquartile range 100–158 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index EClinicalMedicine?

According to LetPub and DOAJ records, EClinicalMedicine is indexed in SCIE, Scopus and DOAJ.

Is EClinicalMedicine open access, and what is the APC?

EClinicalMedicine is a fully open-access journal. APC about USD 6,810.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .